- Tokyo governor who helped get Olympics resigns
- Work resumes at World Cup stadium in Brazil
- Telco Provider MTS Chooses ARRIS Ad-insertion Solution to Deliver the Future of Advertising…Today
- Aston Martin and Daimler sign technical partnership agreements
- Darden Restaurants Reports Second Quarter Diluted Net Earnings Per Share; Declares Its Quarterly Dividend; And Revises Diluted Net Earnings Per Share Outlook For The Full Fiscal Year
- ARRIS Integrates Leading Recommendation Platforms into Merchandiser Multiscreen Solution
- Fight Hunger Bowl will have 2 female officials
- NTSB links apartment explosion to gas leak
- FX Energy Reports Szymanowice-1 Well Flows Gas in Initial Test
- AstraZeneca pays $4.1 billion for diabetes buyout
- Reporter drops lawsuit against Toronto's mayor
- Patriarch off 'Duck Dynasty' after gay comments
- Psychic Friends Network (PFN) announces the upcoming launch of the Psychic Friends Radio Show
- Darden Announces Comprehensive Plan to Enhance Shareholder Value
- NexJ Receives Top Recognition in Fierce Innovation Awards: Healthcare Edition
- Huawei OceanStor 18000 Series Enterprise Storage System Received the Frost & Sullivan 2013 New Product Innovation Leadership Award
- Cayden receives remaining $7.87 million for the completion of the partial Morelos Sur land sale
- NICE Actimize Recognized as Single "Category Leader" for Financial Crime Solutions by Chartis in 2014 RiskTech100® Rankings
- IMD Companies, Inc. Eyes Several Acquisition targets in Fast Emerging Medical Marijuana Sector
- Winnebago Industries Announces First Quarter Of Fiscal 2014 Financial Results
- Scholastic Reports Fiscal 2014 Second Quarter Results
- Commercial International Bank Begins Trading on OTCQX®
- Frito-Lay Awards $50,000 To Texas Public High School Sports Programs
- Can-Fite Granted U.S. Patent for Utilization of A3 Adenosine Receptor as Biomarker to Predict Patient Response to CF101 in Autoimmune Inflammatory Indications
- Entergy Utilities Complete MISO Integration
Latest Headlines Tokyo governor who helped get
Top 10 Most Recent News Articles
Valmet Expands Board Maker Deal in Asia With New Line
If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...
Continue Reading
O-I Glass Faces Class Action: Investor Implications
O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...
Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market
KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...
Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise
Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...
Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
LG's ASIL D Certification: A Game Changer in Autos
Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...
Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps
In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...
Continue Reading
Novo's Semaglutide Shows Promise in MASH Study
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study
Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...
Continue Reading